Hearing that you’ve been diagnosed with bladder cancer naturally leads to one of the first questions most people ask: What stage is it, and what does that mean for my outlook? The answer depends largely on how far the cancer has grown into the bladder wall and whether it has spread to nearby lymph nodes or other parts of the body. In general, the bladder cancer survival rate is highest when the disease is detected early, but it varies considerably from one person to another.
It’s important to understand that bladder cancer stages and survival rates are not the same thing. Staging describes the extent of the cancer, while survival statistics summarize outcomes across large groups of people. They can’t predict how an individual will respond to treatment or what their personal prognosis will be.
If you’re exploring your treatment options, including ITC’s bladder cancer natural treatment, understanding how bladder cancer is staged can help you have more informed conversations with your care team.
How Bladder Cancer Is Staged
Staging is the process healthcare providers use to describe where bladder cancer is located, how deeply it has grown into the bladder wall, and whether it has spread to nearby lymph nodes or other parts of the body. This information helps determine the extent of the disease and guides decisions about treatment and follow-up care.
Doctors use several tests to diagnose and stage bladder cancer, which may include:
- Cystoscopy
- Imaging scans
- Urine tests
- Biopsy of the tumor
After reviewing these results, the cancer is assigned a stage using the internationally recognized TNM staging system, developed by the American Joint Committee on Cancer (AJCC).1
Tumor, Lymph Node, and Metastasis Factors
The TNM system describes bladder cancer using three key pieces of information:
- Tumor (T) – How deeply the tumor has grown into the bladder wall and whether it has reached nearby tissues.
- Lymph Nodes (N) – Whether the cancer has spread to nearby lymph nodes.
- Metastasis (M) – Whether the cancer has spread to distant organs or lymph nodes outside the pelvis.
These three factors are combined to determine the overall stage, ranging from Stage 0 to Stage 4.
Non-Muscle-Invasive vs. Muscle-Invasive Bladder Cancer
One of the most important distinctions in bladder cancer is whether the tumor has grown into the bladder muscle.
- Non-muscle-invasive bladder cancer (NMIBC) – This remains confined to the bladder’s inner lining or the connective tissue just beneath it. It includes most Stage 0 and Stage 1 cancers. Although these tumors have not invaded the muscle, they can recur over time, making regular surveillance an important part of long-term care.
- Muscle-invasive bladder cancer (MIBC) – This develops when the tumor grows into the bladder’s muscular wall. This generally includes Stage 2 disease and beyond. Muscle involvement represents a significant change because it increases the likelihood that cancer cells may spread outside the bladder. This is why treatment for MIBC often involves more extensive approaches, such as surgery to remove the bladder (cystectomy), sometimes combined with other therapies.
Bladder Cancer Stages 0 Through 4
Knowing the stage of bladder cancer helps determine treatment options and expected outcomes. Bladder cancer is divided into five main stages, from Stage 0 to Stage 4, based on how deeply the tumor has grown and whether it has spread beyond the bladder.
Stage 0 Bladder Cancer
Stage 0 bladder cancer is the earliest stage of the disease. Abnormal cells are limited to the bladder’s inner lining and have not invaded the connective tissue or muscle beneath it.
Stage 0 includes two main forms:
- Papillary tumors (Stage 0a) – Growing toward the inside of the bladder
- Flat carcinoma in situ (Stage 0is) – A high-grade cancer that remains on the bladder surface2
Although Stage 0 is highly localized, recurrence is common, so ongoing monitoring with cystoscopy and follow-up testing is often recommended.
Stage 1 Bladder Cancer
In Stage 1, the cancer has grown through the inner lining into the connective tissue beneath it but has not reached the bladder muscle.
Although Stage 1 is still classified as non-muscle-invasive bladder cancer, it carries a higher risk of progression than Stage 0, particularly when the tumor is high grade.3 Here, careful follow-up is important because some Stage 1 tumors can eventually invade deeper layers of the bladder.
Stage 2 Bladder Cancer
Stage 2 bladder cancer means the tumor has grown into the bladder’s muscular wall but has not spread beyond the bladder.
Muscle invasion marks an important change in the extent of the disease. Once cancer reaches the bladder muscle, the risk of spread increases compared with non-muscle-invasive bladder cancer, making accurate staging especially important.
Stage 3 Bladder Cancer
In Stage 3, the cancer has grown beyond the bladder muscle into nearby fatty tissue surrounding the bladder. Depending on the exact stage, it may also involve nearby organs, such as the prostate, uterus, or vagina, or spread to regional lymph nodes within the pelvis.
Not everyone with Stage 3 bladder cancer has the same extent of disease. The specific tumor location, lymph node involvement, and overall health all influence treatment planning and prognosis.
Stage 4 Bladder Cancer
Stage 4 bladder cancer is the most advanced stage. Bladder cancer may have spread to the pelvic or abdominal wall, distant lymph nodes, or organs outside the bladder, such as the lungs, liver, or bones.4
Even within Stage 4, the extent of disease varies considerably. Some people have locally advanced tumors without distant metastases, while others have cancer that has spread to multiple organs. Because of this, Stage 4 does not represent a single prognosis, and treatment recommendations are individualized.
What Is the Bladder Cancer Survival Rate?
A five-year relative survival rate (sometimes written as 5-year relative survival) estimates how many people with bladder cancer are still alive five years after diagnosis compared with people who do not have the disease. It helps researchers understand outcomes across large groups of patients, but it is not a prediction of what will happen to you as an individual.
Another important point is that survival statistics are not always reported by Stage 0–4. The American Cancer Society uses data from the National Cancer Institute’s SEER database, which tracks bladder cancer risk factors and outcomes across the United States and groups bladder cancer as in situ, localized, regional, or distant based on how far it has spread.5
Survival Rates for Localized Bladder Cancer
Localized bladder cancer means the cancer is still confined to the bladder.
According to the American Cancer Society, the five-year relative survival rate is about 73% for localized bladder cancer. For carcinoma in situ, which is limited to the bladder lining, the five-year relative survival rate is 98%. While these numbers are encouraging, they describe large groups of people, and not individual outcomes.
Survival Rates for Regional Bladder Cancer
Regional bladder cancer has spread beyond the bladder to nearby tissues or lymph nodes.
The current five-year relative survival rate is about 41%. However, people with regional bladder cancer can have very different outcomes. The exact extent of the cancer, your overall health, and the treatments you receive all play an important role.
Stage 4 and Distant Bladder Cancer Survival
If bladder cancer spreads to distant organs or lymph nodes, it’s considered a distant disease, which is typically part of Stage 4 bladder cancer.
The American Cancer Society reports a five-year relative survival rate of 9% for distant bladder cancer based on people diagnosed between 2015 and 2021. While this statistic reflects that advanced bladder cancer is more difficult to treat, it does not predict how any one person will do. Treatment options continue to improve, and many of today’s therapies were not widely available when these patients were first diagnosed. Ongoing clinical trials continue to expand the treatment options available for advanced bladder cancer.
Why Survival Statistics Cannot Predict One Person’s Outcome
Survival rates tell us what happened to large groups of people, not what will happen to one individual.
Every person is different. Your age, overall health, the type of bladder cancer you have, and how well your cancer responds to treatment all influence your outlook. Survival statistics also look at people treated several years ago, so they may not fully reflect the impact of newer treatments available today.
Age and Overall Health
Your overall health can affect how well you tolerate treatment and recover from it. People who are otherwise healthy may have more treatment options, but many factors are considered when your healthcare team develops a care plan.6
Cancer Grade and Tumor Behavior
Stage and grade describe different things.
- The stage tells you how far the cancer has spread
- The grade describes how abnormal the cancer cells look under a microscope and how likely they are to grow or spread
Both help doctors understand the cancer and plan treatment.
Recurrence and Progression
Bladder cancer can return after treatment, which is called recurrence. This is especially common with early-stage, non-muscle-invasive bladder cancer, so regular follow-up is an important part of care.
Progression means the cancer has become more advanced than it was before: for example, when it grows deeper into the bladder wall or spreads beyond the bladder.7 Because recurrence and progression are different, ongoing monitoring helps doctors detect changes early.
Where Stage 4 Bladder Cancer May Spread
Stage 4 bladder cancer means the disease has grown beyond the bladder and may have spread to other parts of the body. While every person’s diagnosis is different, the most common sites of distant spread include:
- Lymph nodes
- Bones
- Lungs
- Liver
The location of the cancer can influence the bladder cancer symptoms you experience and your overall prognosis. However, not everyone with Stage 4 bladder cancer has cancer in the same places or to the same extent. The pattern of how fast bladder cancer spreads varies from person to person.
Questions to Ask About Bladder Cancer Stage and Prognosis
Receiving a bladder cancer diagnosis often brings more questions than answers. Consider asking your healthcare provider:
- What stage and grade have been identified?
- Is the cancer non-muscle-invasive or muscle-invasive?
- Is the survival statistic being discussed specific to my extent of disease?
- Which individual factors influence my outlook most?
The more you understand your diagnosis, the better prepared you’ll be to make the right decisions for your health.
Begin Holistic Bladder Cancer Care at ITC
A bladder cancer stage can help guide treatment, but it should never define your future. No statistic can capture your resilience or the goals that matter most to you. That’s why choosing a care team that looks beyond the diagnosis is just as important as understanding the diagnosis itself.
At Immunity Therapy Center, every recommendation begins with a conversation. As a leading Tijuana cancer center, ITC develops personalized treatment plans using alternative cancer treatments that are tailored to your overall health and individual priorities. Our goal is to help you understand every available option, strengthen your body’s natural defenses, and make confident decisions about your care.
If you’re ready to explore a different approach to bladder cancer treatment, schedule a consultation with ITC today.
Sources:
- American Cancer Society. Cancer Staging. https://www.cancer.org/cancer/diagnosis-staging/staging.html
- American Cancer Society. Bladder Cancer Stages. https://www.cancer.org/cancer/types/bladder-cancer/detection-diagnosis-staging/staging.html
- National Cancer Institute. Treatment of Bladder Cancer by Stage. https://www.cancer.gov/types/bladder/treatment/by-stage
- PubMed Central. Bladder cancer. https://pmc.ncbi.nlm.nih.gov/articles/PMC11218610/
- American Cancer Society. Survival Rates for Bladder Cancer. https://www.cancer.org/cancer/types/bladder-cancer/detection-diagnosis-staging/survival-rates.html
- PubMed Central. Impact of Age at Diagnosis of Bladder Cancer on Survival: A Surveillance, Epidemiology, and End Results-Based Study 2004-2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC9903028/
- ScienceDirect. Recurrence and prevention strategies for non-muscle-invasive bladder cancer: A comprehensive review. https://www.sciencedirect.com/science/article/pii/S2214388225000529
At Immunity Therapy Center, all blog content is created to provide high-quality, unbiased, and reliable health information. Each article is written by experienced medical experts, researched using credible medical sources, reviewed for accuracy, fact-checked, and evaluated by ITC’s medical professionals. Our editorial process is designed to reflect current evidence-based information and uphold strong editorial standards.
Articles also include credible third-party sources, listed at the bottom of each page, so readers can access the original source material directly.



